pentoxifylline has been researched along with DDD MPGNII in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YM | 1 |
| Chien, CT | 1 |
| Hu-Tsai, MI | 1 |
| Wu, KD | 1 |
| Tsai, CC | 1 |
| Wu, MS | 1 |
| Tsai, TJ | 1 |
| Marti, HP | 1 |
2 other studies available for pentoxifylline and DDD MPGNII
| Article | Year |
|---|---|
Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Topics: Animals; Antibodies, Monoclonal; Base Sequence; Cell Division; Chemokine CCL2; Collagen; Disease Mod | 1999 |
New strategy to treat glomerular inflammation by inhibition of mesangial cell matrix metalloproteinases.
Topics: Animals; Apoptosis; Benzyl Compounds; Cell Division; Culture Techniques; Dexamethasone; Dose-Respons | 2000 |